Displaying 1 - 20 of 197 results
Released Company Title Industry Topic
13 Jan 2020
23:00 CET
INNATE PHARMA French regulatory agency agrees lacutamab TELLOMAK trial can resume recruitment in Sézary syndrome and mycosis fungoides Biotechnology Other subject
13 Jan 2020
23:00 CET
INNATE PHARMA L’agence réglementaire française autorise la reprise du recrutement dans l’essai TELLOMAK avec lacutamab chez les patients atteints de syndrome de Sézary et mycosis fongoïde Biotechnology Other subject
09 Jan 2020
07:00 CET
INNATE PHARMA INNATE PHARMA PROVIDES UPDATE FROM REGULATORY AGENCIES ON LACUTAMAB TELLOMAK TRIAL Biotechnology Corporate life
09 Jan 2020
07:00 CET
INNATE PHARMA INNATE PHARMA PRESENTE UNE MISE A JOUR DES AUTORITES RÉGLEMENTAIRES SUR L’ESSAI TELLOMAK DE LACUTAMAB Biotechnology Corporate life
02 Jan 2020
07:00 CET
INNATE PHARMA L'agence européenne du médicament accepte le dossier de demande d'enregistrement réglementaire de Lumoxiti dans la leucémie à tricholeucocytes en rechute ou réfractaire Biotechnology Products and services
02 Jan 2020
07:00 CET
INNATE PHARMA The European Medicines Agency accepts the regulatory submission for Lumoxiti in relapsed or refractory hairy cell leukemia Biotechnology Products and services
13 Dec 2019
07:00 CET
INNATE PHARMA INNATE PHARMA PRÉSENTE UNE MISE À JOUR SUR L’ESSAI TELLOMAK DE LACUTAMAB Biotechnology Other subject
13 Dec 2019
07:00 CET
INNATE PHARMA Innate Pharma Provides Update on Lacutamab Tellomak Trial Biotechnology Other subject
08 Dec 2019
15:00 CET
INNATE PHARMA Innate Pharma highlights FDA-approved Lumoxiti® at ASH 2019 Biotechnology Products and services
08 Dec 2019
15:00 CET
INNATE PHARMA Innate Pharma présente Lumoxiti®, médicament approuvé par la FDA, au congrès de l'ASH 2019 Biotechnology Products and services
04 Dec 2019
07:00 CET
INNATE PHARMA INNATE PHARMA RELEASES ITS FINANCIAL CALENDAR FOR 2020 Biotechnology Meetings / events
04 Dec 2019
07:00 CET
INNATE PHARMA INNATE PHARMA PUBLIE SON CALENDRIER FINANCIER POUR 2020 Biotechnology Meetings / events
03 Dec 2019
07:00 CET
INNATE PHARMA Innate Pharma Certified as a Great Place to Work® Biotechnology Meetings / events
03 Dec 2019
07:00 CET
INNATE PHARMA Innate Pharma certifiée Great Place to Work® Biotechnology Meetings / events
13 Nov 2019
07:00 CET
INNATE PHARMA Information financière du troisième trimestre 2019 Biotechnology Products and services
13 Nov 2019
07:00 CET
INNATE PHARMA Innate Pharma third quarter 2019 report Biotechnology Products and services
07 Nov 2019
07:00 CET
INNATE PHARMA Innate Pharma partagera de nouvelles données de long terme sur Lumoxiti au congrès annuel 2019 de la société américaine d'hématologie Biotechnology Products and services
07 Nov 2019
07:00 CET
INNATE PHARMA Innate Pharma to share new long-term data on Lumoxiti at 2019 American Society of Hematology annual meeting Biotechnology Products and services
06 Nov 2019
07:00 CET
INNATE PHARMA Innate Pharma announces preclinical data presentations at SITC 2019 Biotechnology Products and services
06 Nov 2019
07:00 CET
INNATE PHARMA NUMBER OF SHARES AND VOTING RIGHTS OF INNATE PHARMA AS AT NOVEMBER 1, 2019 Biotechnology Change in Capital